Roxarsone
Roxarsone is an organic compound used as a feed additive in the poultry industry. It is a derivative of arsenic, and is used to promote growth, kill parasites, and improve meat pigmentation.
History[edit]
Roxarsone was first synthesized in the 1960s and has been used in the poultry industry since the 1970s. It was initially developed as a means to control parasites in chickens, but its use has expanded to include promoting growth and improving meat pigmentation.
Use[edit]
Roxarsone is typically added to poultry feed in small amounts. It is believed to promote growth by improving feed efficiency and controlling parasites. It also improves the color of meat, making it more appealing to consumers. However, its use has been controversial due to concerns about arsenic contamination in poultry products and the environment.
Health and environmental concerns[edit]
Roxarsone is metabolized in the chicken's body and excreted in the feces. This can lead to arsenic contamination of the environment when the chicken manure is used as fertilizer. There are also concerns about the potential for arsenic to accumulate in the meat of chickens fed roxarsone, posing a risk to human health.
In 2011, the U.S. Food and Drug Administration (FDA) conducted a study that found higher levels of inorganic arsenic, a known carcinogen, in the livers of chickens treated with roxarsone than in untreated chickens. This led to a voluntary suspension of the sale of roxarsone in the United States.
Regulation[edit]
The use of roxarsone in poultry feed is regulated in many countries. In the United States, the FDA has not banned the use of roxarsone, but it is not currently being sold. In the European Union, the use of arsenic-based feed additives, including roxarsone, is banned.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

